PETER J. GRAHAM

Insider Reports History

Location
New York, NY
Signature
/s/ Lisa Kallebo, Attorney-in-Fact for Peter Graham
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by PETER J. GRAHAM:

Company Role Class Num Shares Value Price $ Report Date Ownership
ADC Therapeutics SA Chief Legal Officer Common Shares 359,034 $1,181,221 $3.29 06 Dec 2025 Direct
ANTARES PHARMA, INC. EVP, General Counsel, Chief Compliance Officer and Secretary Common Stock 0 $5.60 24 May 2022 Direct
ANTARES PHARMA, INC. EVP, General Counsel, Chief Compliance Officer and Secretary Stock Option (right to buy) 0 24 May 2022 Direct

Insider Reports Filed by PETER J. GRAHAM

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ADCT ADC Therapeutics SA 06 Dec 2025 1 -$162,881 4 Chief Legal Officer 09 Dec 2025, 17:09
ADCT ADC Therapeutics SA 13 Feb 2025 1 +$354,200 4 Chief Legal Officer 14 Feb 2025, 18:23
ADCT ADC Therapeutics SA 06 Dec 2024 1 -$129,764 4 Chief Legal Officer 09 Dec 2024, 20:35
ADCT ADC Therapeutics SA 02 Jan 2024 0 $0 3 Chief Legal Officer 02 Jan 2024, 20:08
/report/000089924322019789-graham-peter-j-2022-05-24 ANTARES PHARMA, INC. 24 May 2022 10 -$4,148,721 4 EVP, General Counsel, Chief Compliance Officer and Secretary 26 May 2022, 17:25
/report/000101616922000031-graham-peter-j-2022-03-03 ANTARES PHARMA, INC. 03 Mar 2022 2 -$51,813 4 EVP General Counsel, Secretary 04 Mar 2022, 17:34
/report/000101616922000016-graham-peter-j-2022-02-16 ANTARES PHARMA, INC. 16 Feb 2022 2 -$48,674 4 EVP General Counsel, Secretary 18 Feb 2022, 18:19
/report/000120919121040328-graham-peter-j-2021-06-10 ANTARES PHARMA, INC. 10 Jun 2021 4 +$211,791 4 EVP General Counsel, Secretary 14 Jun 2021, 18:21
/report/000120919121039591-graham-peter-j-2021-06-08 ANTARES PHARMA, INC. 08 Jun 2021 1 -$70,222 4 EVP General Counsel, Secretary 10 Jun 2021, 17:38